Bridgeway Capital Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30,101
| Closed | -$331K | – | 1207 |
|
|
2024
Q3 | $331K | Hold |
30,101
| – | – | 0.01% | 956 |
|
|
2024
Q2 | $274K | Sell |
30,101
-5,000
| -14% | -$45.5K | 0.01% | 985 |
|
|
2024
Q1 | $494K | Sell |
35,101
-61,200
| -64% | -$861K | 0.01% | 934 |
|
|
2023
Q4 | $740K | Buy |
96,301
+31,100
| +48% | +$239K | 0.02% | 836 |
|
|
2023
Q3 | $486K | Buy |
65,201
+30,201
| +86% | +$225K | 0.01% | 876 |
|
|
2023
Q2 | $292K | Hold |
35,000
| – | – | 0.01% | 1052 |
|
|
2023
Q1 | $466K | Hold |
35,000
| – | – | 0.01% | 907 |
|
|
2022
Q4 | $521K | Hold |
35,000
| – | – | 0.01% | 873 |
|
|
2022
Q3 | $316K | Sell |
35,000
-79,279
| -69% | -$716K | 0.01% | 1018 |
|
|
2022
Q2 | $343K | Buy |
114,279
+50,000
| +78% | +$150K | 0.01% | 965 |
|
|
2022
Q1 | $431K | Buy |
64,279
+19,279
| +43% | +$129K | 0.01% | 975 |
|
|
2021
Q4 | $243K | Buy |
+45,000
| New | +$243K | ﹤0.01% | 1135 |
|
|
2021
Q2 | – | Sell |
-17,933
| Closed | -$311K | – | 1334 |
|
|
2021
Q1 | $311K | Buy |
17,933
+15,850
| +761% | +$275K | 0.01% | 1217 |
|
|
2020
Q4 | $27K | Sell |
2,083
-12,967
| -86% | -$168K | ﹤0.01% | 1299 |
|
|
2020
Q3 | $559K | Hold |
15,050
| – | – | 0.01% | 846 |
|
|
2020
Q2 | $581K | Buy |
15,050
+5,883
| +64% | +$227K | 0.01% | 807 |
|
|
2020
Q1 | $228K | Buy |
+9,167
| New | +$228K | 0.01% | 1019 |
|
|
2019
Q4 | – | Sell |
-3,483
| Closed | -$113K | – | 1313 |
|
|
2019
Q3 | $113K | Hold |
3,483
| – | – | ﹤0.01% | 1236 |
|
|
2019
Q2 | $169K | Buy |
+3,483
| New | +$169K | ﹤0.01% | 1201 |
|
|
2018
Q4 | – | Sell |
-1,505
| Closed | -$72K | – | 1373 |
|
|
2018
Q3 | $72K | Hold |
1,505
| – | – | ﹤0.01% | 1398 |
|
|
2018
Q2 | $87K | Buy |
+1,505
| New | +$87K | ﹤0.01% | 1371 |
|
|
2017
Q2 | – | Sell |
-1,689
| Closed | -$162K | – | 1418 |
|
|
2017
Q1 | $162K | Hold |
1,689
| – | – | ﹤0.01% | 1304 |
|
|
2016
Q4 | $366K | Buy |
1,689
+833
| +97% | +$181K | ﹤0.01% | 1182 |
|
|
2016
Q3 | $316K | Buy |
856
+394
| +85% | +$145K | ﹤0.01% | 1230 |
|
|
2016
Q2 | $102K | Buy |
+462
| New | +$102K | ﹤0.01% | 1381 |
|